HIGHLIGHTS
- who: . et al. from the McGill University, Canada have published the Article: Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study, in the Journal: (JOURNAL)
- what: This study therefore assessed the rate of patients who achieved remission or LDA and showed a reduction of DAS28-CRP value greater than or equal to 1.2 from baseline to week 52 and confirmed that no differences were found between both groups (p-value=0.202). The authors have waived such analysis for the following reasons: the lack . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.